Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Terns Pharmaceuticals (TERN) Retained Earnings: 2020-2022

Historic Retained Earnings for Terns Pharmaceuticals (TERN) over the last 3 years, with Dec 2022 value amounting to -$242.4 million.

  • Terns Pharmaceuticals' Retained Earnings fell 37.52% to -$311.6 million in Q3 2023 from the same period last year, while for Sep 2023 it was -$311.6 million, marking a year-over-year decrease of 37.52%. This contributed to the annual value of -$242.4 million for FY2022, which is 33.14% down from last year.
  • As of FY2022, Terns Pharmaceuticals' Retained Earnings stood at -$242.4 million, which was down 33.14% from -$182.1 million recorded in FY2021.
  • In the past 5 years, Terns Pharmaceuticals' Retained Earnings ranged from a high of -$131.9 million in FY2020 and a low of -$242.4 million during FY2022.
  • Its 3-year average for Retained Earnings is -$185.5 million, with a median of -$182.1 million in 2021.
  • Data for Terns Pharmaceuticals' Retained Earnings shows a maximum YoY plummeted of 38.02% (in 2021) over the last 5 years.
  • Over the past 3 years, Terns Pharmaceuticals' Retained Earnings (Yearly) stood at -$131.9 million in 2020, then slumped by 38.02% to -$182.1 million in 2021, then crashed by 33.14% to -$242.4 million in 2022.